July 5, 2023 — With heart disease the most common cause of death worldwide, researchers have attempted to quantify how ...
July 5, 2023 — Research presented during the American Society of Echocardiography’s 34th Annual Scientific Sessions, ASE ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...
July 3, 2023 — Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first ...
July 3, 2023 — Researchers at the UNC School of Medicine, UNC McAllister Heart Institute, and the UNC Lineberger ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...
June 30, 2023 — Of approximately 250,000 Americans diagnosed with acute pulmonary embolism, or PE, in emergency ...
June 30, 2023 — A new study published in The Lancet has revealed the most extensive analysis to date on what led to the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 30, 2023 — Women with atrial fibrillation progress more rapidly to cognitive impairment and dementia than men with ...
June 29, 2023 — UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...
June 29, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 29, 2023 — At the conclusion of the American Society of Echocardiography 2023 Scientific Sessions, ASE 2023, the ...
June 29, 2023 — A large, multi-center study presented during the American Society of Echocardiography’s (ASE) 34th ...
June 28, 2023 — Bristol Myers Squibb announced that the European Commission (EC) has approved CAMZYOS (mavacamten, 2.5 ...